0000899243-16-013280.txt : 20160212 0000899243-16-013280.hdr.sgml : 20160212 20160212193004 ACCESSION NUMBER: 0000899243-16-013280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160210 FILED AS OF DATE: 20160212 DATE AS OF CHANGE: 20160212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEOSTASIS THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001445283 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 617-225-0096 MAIL ADDRESS: STREET 1: 200 TECHNOLOGY SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: PROTEOSTASIS THERAPEUTICS INC DATE OF NAME CHANGE: 20080916 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chhabra Meenu CENTRAL INDEX KEY: 0001534200 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37695 FILM NUMBER: 161422029 MAIL ADDRESS: STREET 1: 1600 FAIRVIEW AVE. E. STREET 2: SUITE 300 CITY: SEATTLE STATE: WA ZIP: 98102 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-02-10 0 0001445283 PROTEOSTASIS THERAPEUTICS, INC. PTI 0001534200 Chhabra Meenu 200 TECHNOLOGY SQUARE, 4TH FLOOR CAMBRIDGE MA 02139 1 1 0 0 President and CEO Employee Stock Option (Right to Buy) 8.00 2016-02-10 4 A 0 162861 0.00 A 2026-02-10 Common Stock 162861 162861 D These securities shall vest and become exercisable in a series of installments, with the first installment to become exercisable for 25% of the underlying common stock on February 10, 2017, and thereafter vesting and becoming exercisable in quarterly installments as nearly equal as practicable (as determined by the Issuer in its reasonable discretion), until such stock option becomes fully exercisable on February 10, 2020, provided that the Reporting Person remains an employee of Issuer at all times during the applicable vesting period of such securities. Janet L. Smart, Attorney-in-Fact 2016-02-12